Business
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the publication of a new feature article on BreastCT.com titled “AI Is Reshaping Breast Imaging, and IzoView
About this update from Izotropic Corp.
[{"type":"image","alt":"Izotropic","displaySize":"","headline":null,"caption":"Izotropic","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/342f0108283f64b41bf05ed2af94ca63"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BChRXr4MzGGT2dgplDeEaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/342f0108283f64b41bf05ed2af94ca63","width":300,"height":83}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the publication of a new feature article on BreastCT.com titled “AI Is Reshaping Breast Imaging, and IzoView Was Built for What Comes Next.”","length":547,"tagName":"p"},{"type":"text","content":"The article is the latest addition to BreastCT.com, Izotropic’s growing educational content platform developed to support the Company’s commercialization strategy, raise awareness of its flagship device, the IzoView Breast CT Imaging System, and define its leadership in the emerging category of AI-integrated breast imaging.","length":330,"tagName":"p"},{"type":"text","content":"As global demand accelerates for advanced screening solutions, particularly in patients with dense breast tissue, this article highlights why legacy systems fall short and how IzoView was purpose-built for the future of intelligent imaging.","length":240,"tagName":"p"},{"type":"text","content":"Key takeaways from the article include:","length":39,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"AI Is Improving Breast Cancer Detection at Scale Global studies and new FDA-approved tools confirm AI boosts accuracy and speeds up diagnosis, setting the stage for a new standard in imaging.","length":192,"tagName":"p"}]},{"val":[{"type":"text","content":"Outdated Imaging Systems Limit AI's Full Potential Most AI tools are retrofitted onto legacy breast imaging systems that can struggle with dense breast tissue, but they can't overcome th...